HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 937-948 of 1,811
Drug study icon
TerminatedNCT06431256

Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD

Official study title

Phase 3, Multicenter, 3-Week Fixed-dose, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy, Safety and PK Study of Evening Dosed Methylphenidate Hydrochloride ER Capsules (HLD200) in Children Aged 4-5 Years With ADHD

This study ended early.

Multiple locations, including Dothan
ADHDMedication studyAges 4–5
Countries
United States
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Behavioral study icon
CompletedNCT03747887

Enhancing IEPs of Children With ADHD Using Daily Report Cards

Official study title

Enhancing IEPs of Children With ADHD Using Daily Report Cards: An Efficacy Trial

This study has finished and is no longer accepting participants.

In Buffalo
ADHDBehavioural studyAges 5–14
Countries
United States
Sponsor
State University of New York at Buffalo
Drug study icon
CompletedNCT02695355

ERP Based Single-dose Predictions of Stimulants

What is this study about?

Researchers studied Methylphenidate (MPH) to find out how it affected ADHD symptoms in children with ADHD.

This study has finished and is no longer accepting participants.

In Fredrikstad
ADHDMedication studyAges 8–17
Countries
Norway
Sponsor
Ostfold Hospital Trust
Drug study icon
CompletedNCT02450890

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Official study title

A Phase III, Multi-Center, Randomized, Double-blind, Placebo Controlled, Two-way Cross-over Clinical Study to Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

This study has finished and is no longer accepting participants.

Multiple locations, including Chiayi City
ADHDMedication studyAges 6–18
Countries
Taiwan
Sponsor
Orient Pharma Co., Ltd.
Drug study icon
WithdrawnNCT01913912

Event Rate and Effects of Stimulants in ADHD

Official study title

Can Changing the Rate at Which Information is Presented Alter the Effects of Stimulants on ADHD Information Processing. Testing a Prediction of the State Regulation Deficit Model.

This study was withdrawn before enrollment.

In Ghent
ADHDMedication studyAges 7–12
Countries
Belgium
Sponsor
University Ghent

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.